Association of patatin-like phospholipase domain-containing protein 3 gene polymorphisms with susceptibility of nonalcoholic fatty liver disease in a Han Chinese population
Open Access
- 1 August 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 95 (33) , e4569
Abstract
Gene polymorphisms had been found to be associated with increased risk of nonalcoholic fatty liver disease (NAFLD). The aim of the present study was to assess the association between rs2896019 and rs3810622 in PNPLA3 with the susceptibility to NAFLD in Han Chinese population. A total of 384 NAFLD patients and 384 controls were enrolled in the study. Blood samples collected from each subject were used for biochemical index analysis and DNA extraction. Genotyping analyses of PNPLA3 rs2896019 and rs3810622 were performed by real-time PCR methods. Results showed that patients with genotype GG of rs2896019 had a higher incidence of NAFLD than patients with genotypes GT and TT (62.4% vs 52.0% and 43.3%, respectively, P = 0.002), and a higher risk of moderate to severe NAFLD than patients with genotypes GT and TT (60.3% vs 46.2% and 40.2%, respectively, P = 0.03). Furthermore, patients with genotype GG of rs2896019 had higher levels of low-density lipoprotein (LDL, P < 0.001), ALT (P = 0.003), and AST (P = 0.002). Patients with genotype TT of rs3810622 had a higher incidence of NAFLD than patients with genotypes CT and CC (56.7% vs 48.4% and 41.5%, respectively, P = 0.013). Likewise, patients with genotype TT of rs3810622 had higher levels of ALT (P = 0.021) and blood glucose (GLU) (P = 0.034). Haplotype association analysis showed that GT haplotype conferred a statistically significant increased risk for NAFLD (OR = 1.49; 95% CI = 1.20–1.84, P < 0.01). These results suggest that PNPLA3 rs2896019 and rs3810622 polymorphisms significantly contribute to increased NAFLD risk in Han Chinese population.Keywords
This publication has 25 references indexed in Scilit:
- I148M variant of PNPLA3 increases the susceptibility to non‐alcoholic fatty liver disease caused by obesity and metabolic disordersAlimentary Pharmacology & Therapeutics, 2016
- Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and OutcomesClinical Gastroenterology and Hepatology, 2015
- Prevalence of Nonalcoholic Fatty Liver Disease and EconomyDigestive Diseases and Sciences, 2015
- The Frequent Adiponutrin (PNPLA3) Variant p.Ile148Met Is Associated with Early Liver Injury: Analysis of a German Pediatric CohortGastroenterology Research and Practice, 2015
- Role of the PNPLA3 I148M Polymorphism in Nonalcoholic Fatty Liver Disease and Fibrosis in KoreaDigestive Diseases and Sciences, 2014
- PNPLA3-Associated Steatohepatitis: Toward a Gene-Based Classification of Fatty Liver DiseaseSeminars in Liver Disease, 2013
- Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in JapanHuman Genetics, 2013
- Genetic Polymorphisms of the Human PNPLA3 Gene Are Strongly Associated with Severity of Non-Alcoholic Fatty Liver Disease in JapanesePLOS ONE, 2012
- Have guidelines addressing physical activity been established in nonalcoholic fatty liver disease?World Journal of Gastroenterology, 2012
- Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammationCurrent Opinion in Clinical Nutrition and Metabolic Care, 2010